Log in
Enquire now
‌

US Patent 11220490 Ureas having androgen receptor degradation activity and uses thereof

Patent 11220490 was granted and assigned to Accutar Biotech on January, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Accutar Biotech
Accutar Biotech
Current Assignee
Accutar Biotech
Accutar Biotech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11220490
Date of Patent
January 11, 2022
Patent Application Number
17331015
Date Filed
May 26, 2021
Patent Citations Received
‌
US Patent 11787778 Bi-functional compounds and methods for targeted ubiquitination of androgen receptor
Patent Primary Examiner
‌
Samira J Jean-Louis
Patent abstract

The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11220490 Ureas having androgen receptor degradation activity and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.